Loading…
Incidence and prognosis of patients with small intestinal neuroendocrine tumors in a population based nationwide study
Small intestinal neuroendocrine tumours (SI-NETs) are the most frequent malignant tumours of the small intestine. Population based studies on SI-NETs are scarce. We aimed to examine the incidence, presentation of disease and prognosis of SI-NET and to determine patient prognosis in those undergoing...
Saved in:
Published in: | Cancer epidemiology 2022-08, Vol.79, p.102197-102197, Article 102197 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c364t-be3a5a913521f7698d7219472f3a5d530e2af93d0a736ac1d8d7f69541d16c13 |
---|---|
cites | cdi_FETCH-LOGICAL-c364t-be3a5a913521f7698d7219472f3a5d530e2af93d0a736ac1d8d7f69541d16c13 |
container_end_page | 102197 |
container_issue | |
container_start_page | 102197 |
container_title | Cancer epidemiology |
container_volume | 79 |
creator | Snorradottir, S. Asgeirsdottir, A. Rögnvaldsson, S. Jonasson, JG Björnsson, ES |
description | Small intestinal neuroendocrine tumours (SI-NETs) are the most frequent malignant tumours of the small intestine. Population based studies on SI-NETs are scarce. We aimed to examine the incidence, presentation of disease and prognosis of SI-NET and to determine patient prognosis in those undergoing emergency or elective surgery.
This was a retrospective population-based study. Information on all patients diagnosed with neuroendocrine tumours of the small intestine (excluding duodenum) from the beginning of the Icelandic Cancer Registry and the pathology departments in the country (1966–2017). Detailed phenotypic information was obtained from medical records on symptoms at diagnosis, treatment, recurrence and survival.
A total of 113 patients with SI-NETs were identified, 3 patients were excluded due to lack of data and/or diagnostic error, leaving 110 patients for final analysis. The incidence of SI-NET was 0.78/100,000 and did not increase during the study period. A total of 42 % (n = 46) of patients were diagnosed incidentally. Long-term prognosis, after a landmark of 12 months, was better in patients who were diagnosed incidentally (HR 0.52; p = 0.03). Overall 89 % (n = 98) of cases underwent surgical resection of the primary tumor, 31 % (n = 30) patients acute or semi-acute surgery and 69 % (n = 68) elective surgery. Emergency surgery was associated with a 6-fold risk of death in the first 12 months after surgery (HR: 5.99; p = 0.01) and associated with more severe surgical complications. However, there was no difference in the long-term risk of death after the first 12 months (HR: 1.39; p = 0.27).
The incidence of SI-NETs has not changed significantly in the last decades. Incidentally diagnosed SI-NET was associated with a favorable long-term prognosis. Emergency surgery in patients with SI-NET was associated with a significantly worse short-term risk of mortality compared to those who underwent elective surgery.
•Despite advances in imaging and endoscopy incidence of SI-NETs did not change over time.•Incidental diagnosis of SI-NET was associated with an earlier stage disease and improved long-term prognosis.•Emergency surgery was associated with a 6-fold risk of death in the first 12 months after surgery. |
doi_str_mv | 10.1016/j.canep.2022.102197 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2678427464</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1877782122001023</els_id><sourcerecordid>2689039008</sourcerecordid><originalsourceid>FETCH-LOGICAL-c364t-be3a5a913521f7698d7219472f3a5d530e2af93d0a736ac1d8d7f69541d16c13</originalsourceid><addsrcrecordid>eNp9kTtPwzAUhSMEEuXxC1gssbC0-JHYycCAKh6VKrF0YLNc-wZcpXawnVb997gtYmBgsn31Hd977imKG4InBBN-v5po5aCfUExprlDSiJNiRGohxqJm76e_d0rOi4sYVxhzTkg1KjYzp60BpwEpZ1Af_Ifz0UbkW9SrZMGliLY2faK4Vl2HrEsQk3WqQw6G4MEZr4N1gNKw9iFmACnU-37osto7tFQRDHKHxzZ3QjENZndVnLWqi3D9c14Wi-enxfR1PH97mU0f52PNeJnGS2CqUg1hFSWt4E1tRPZWCtrmuqkYBqrahhmsBONKE5OBljdVSQzhmrDL4u74bfb1NeTB5dpGDV2Xt-WHKCkXdUlFycuM3v5BV34I2eeeqhvMGozrTLEjpYOPMUAr-2DXKuwkwXIfhVzJQxRyH4U8RpFVD0cVZKsbC0FGbfc7NzaATtJ4-6_-G0TUlJc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2689039008</pqid></control><display><type>article</type><title>Incidence and prognosis of patients with small intestinal neuroendocrine tumors in a population based nationwide study</title><source>ScienceDirect Journals</source><creator>Snorradottir, S. ; Asgeirsdottir, A. ; Rögnvaldsson, S. ; Jonasson, JG ; Björnsson, ES</creator><creatorcontrib>Snorradottir, S. ; Asgeirsdottir, A. ; Rögnvaldsson, S. ; Jonasson, JG ; Björnsson, ES</creatorcontrib><description>Small intestinal neuroendocrine tumours (SI-NETs) are the most frequent malignant tumours of the small intestine. Population based studies on SI-NETs are scarce. We aimed to examine the incidence, presentation of disease and prognosis of SI-NET and to determine patient prognosis in those undergoing emergency or elective surgery.
This was a retrospective population-based study. Information on all patients diagnosed with neuroendocrine tumours of the small intestine (excluding duodenum) from the beginning of the Icelandic Cancer Registry and the pathology departments in the country (1966–2017). Detailed phenotypic information was obtained from medical records on symptoms at diagnosis, treatment, recurrence and survival.
A total of 113 patients with SI-NETs were identified, 3 patients were excluded due to lack of data and/or diagnostic error, leaving 110 patients for final analysis. The incidence of SI-NET was 0.78/100,000 and did not increase during the study period. A total of 42 % (n = 46) of patients were diagnosed incidentally. Long-term prognosis, after a landmark of 12 months, was better in patients who were diagnosed incidentally (HR 0.52; p = 0.03). Overall 89 % (n = 98) of cases underwent surgical resection of the primary tumor, 31 % (n = 30) patients acute or semi-acute surgery and 69 % (n = 68) elective surgery. Emergency surgery was associated with a 6-fold risk of death in the first 12 months after surgery (HR: 5.99; p = 0.01) and associated with more severe surgical complications. However, there was no difference in the long-term risk of death after the first 12 months (HR: 1.39; p = 0.27).
The incidence of SI-NETs has not changed significantly in the last decades. Incidentally diagnosed SI-NET was associated with a favorable long-term prognosis. Emergency surgery in patients with SI-NET was associated with a significantly worse short-term risk of mortality compared to those who underwent elective surgery.
•Despite advances in imaging and endoscopy incidence of SI-NETs did not change over time.•Incidental diagnosis of SI-NET was associated with an earlier stage disease and improved long-term prognosis.•Emergency surgery was associated with a 6-fold risk of death in the first 12 months after surgery.</description><identifier>ISSN: 1877-7821</identifier><identifier>EISSN: 1877-783X</identifier><identifier>DOI: 10.1016/j.canep.2022.102197</identifier><language>eng</language><publisher>New York: Elsevier Ltd</publisher><subject>Age groups ; Cancer ; Carcinoid ; Colorectal cancer ; Complications ; Data analysis ; Duodenum ; Emergencies ; Epidemiology ; Error analysis ; Intestine ; Lymphatic system ; Medical prognosis ; Medical records ; Medical treatment ; Metastasis ; Mortality ; Neuroendocrine tumors ; Pathology ; Patients ; Population ; Population studies ; Population-based studies ; Prognosis ; Risk ; Signs and symptoms ; Small intestinal neuroendocrine tumors ; Small intestine ; Surgery ; Survival analysis ; Tumors</subject><ispartof>Cancer epidemiology, 2022-08, Vol.79, p.102197-102197, Article 102197</ispartof><rights>2022 Elsevier Ltd</rights><rights>2022. Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c364t-be3a5a913521f7698d7219472f3a5d530e2af93d0a736ac1d8d7f69541d16c13</citedby><cites>FETCH-LOGICAL-c364t-be3a5a913521f7698d7219472f3a5d530e2af93d0a736ac1d8d7f69541d16c13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids></links><search><creatorcontrib>Snorradottir, S.</creatorcontrib><creatorcontrib>Asgeirsdottir, A.</creatorcontrib><creatorcontrib>Rögnvaldsson, S.</creatorcontrib><creatorcontrib>Jonasson, JG</creatorcontrib><creatorcontrib>Björnsson, ES</creatorcontrib><title>Incidence and prognosis of patients with small intestinal neuroendocrine tumors in a population based nationwide study</title><title>Cancer epidemiology</title><description>Small intestinal neuroendocrine tumours (SI-NETs) are the most frequent malignant tumours of the small intestine. Population based studies on SI-NETs are scarce. We aimed to examine the incidence, presentation of disease and prognosis of SI-NET and to determine patient prognosis in those undergoing emergency or elective surgery.
This was a retrospective population-based study. Information on all patients diagnosed with neuroendocrine tumours of the small intestine (excluding duodenum) from the beginning of the Icelandic Cancer Registry and the pathology departments in the country (1966–2017). Detailed phenotypic information was obtained from medical records on symptoms at diagnosis, treatment, recurrence and survival.
A total of 113 patients with SI-NETs were identified, 3 patients were excluded due to lack of data and/or diagnostic error, leaving 110 patients for final analysis. The incidence of SI-NET was 0.78/100,000 and did not increase during the study period. A total of 42 % (n = 46) of patients were diagnosed incidentally. Long-term prognosis, after a landmark of 12 months, was better in patients who were diagnosed incidentally (HR 0.52; p = 0.03). Overall 89 % (n = 98) of cases underwent surgical resection of the primary tumor, 31 % (n = 30) patients acute or semi-acute surgery and 69 % (n = 68) elective surgery. Emergency surgery was associated with a 6-fold risk of death in the first 12 months after surgery (HR: 5.99; p = 0.01) and associated with more severe surgical complications. However, there was no difference in the long-term risk of death after the first 12 months (HR: 1.39; p = 0.27).
The incidence of SI-NETs has not changed significantly in the last decades. Incidentally diagnosed SI-NET was associated with a favorable long-term prognosis. Emergency surgery in patients with SI-NET was associated with a significantly worse short-term risk of mortality compared to those who underwent elective surgery.
•Despite advances in imaging and endoscopy incidence of SI-NETs did not change over time.•Incidental diagnosis of SI-NET was associated with an earlier stage disease and improved long-term prognosis.•Emergency surgery was associated with a 6-fold risk of death in the first 12 months after surgery.</description><subject>Age groups</subject><subject>Cancer</subject><subject>Carcinoid</subject><subject>Colorectal cancer</subject><subject>Complications</subject><subject>Data analysis</subject><subject>Duodenum</subject><subject>Emergencies</subject><subject>Epidemiology</subject><subject>Error analysis</subject><subject>Intestine</subject><subject>Lymphatic system</subject><subject>Medical prognosis</subject><subject>Medical records</subject><subject>Medical treatment</subject><subject>Metastasis</subject><subject>Mortality</subject><subject>Neuroendocrine tumors</subject><subject>Pathology</subject><subject>Patients</subject><subject>Population</subject><subject>Population studies</subject><subject>Population-based studies</subject><subject>Prognosis</subject><subject>Risk</subject><subject>Signs and symptoms</subject><subject>Small intestinal neuroendocrine tumors</subject><subject>Small intestine</subject><subject>Surgery</subject><subject>Survival analysis</subject><subject>Tumors</subject><issn>1877-7821</issn><issn>1877-783X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kTtPwzAUhSMEEuXxC1gssbC0-JHYycCAKh6VKrF0YLNc-wZcpXawnVb997gtYmBgsn31Hd977imKG4InBBN-v5po5aCfUExprlDSiJNiRGohxqJm76e_d0rOi4sYVxhzTkg1KjYzp60BpwEpZ1Af_Ifz0UbkW9SrZMGliLY2faK4Vl2HrEsQk3WqQw6G4MEZr4N1gNKw9iFmACnU-37osto7tFQRDHKHxzZ3QjENZndVnLWqi3D9c14Wi-enxfR1PH97mU0f52PNeJnGS2CqUg1hFSWt4E1tRPZWCtrmuqkYBqrahhmsBONKE5OBljdVSQzhmrDL4u74bfb1NeTB5dpGDV2Xt-WHKCkXdUlFycuM3v5BV34I2eeeqhvMGozrTLEjpYOPMUAr-2DXKuwkwXIfhVzJQxRyH4U8RpFVD0cVZKsbC0FGbfc7NzaATtJ4-6_-G0TUlJc</recordid><startdate>202208</startdate><enddate>202208</enddate><creator>Snorradottir, S.</creator><creator>Asgeirsdottir, A.</creator><creator>Rögnvaldsson, S.</creator><creator>Jonasson, JG</creator><creator>Björnsson, ES</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>202208</creationdate><title>Incidence and prognosis of patients with small intestinal neuroendocrine tumors in a population based nationwide study</title><author>Snorradottir, S. ; Asgeirsdottir, A. ; Rögnvaldsson, S. ; Jonasson, JG ; Björnsson, ES</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c364t-be3a5a913521f7698d7219472f3a5d530e2af93d0a736ac1d8d7f69541d16c13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Age groups</topic><topic>Cancer</topic><topic>Carcinoid</topic><topic>Colorectal cancer</topic><topic>Complications</topic><topic>Data analysis</topic><topic>Duodenum</topic><topic>Emergencies</topic><topic>Epidemiology</topic><topic>Error analysis</topic><topic>Intestine</topic><topic>Lymphatic system</topic><topic>Medical prognosis</topic><topic>Medical records</topic><topic>Medical treatment</topic><topic>Metastasis</topic><topic>Mortality</topic><topic>Neuroendocrine tumors</topic><topic>Pathology</topic><topic>Patients</topic><topic>Population</topic><topic>Population studies</topic><topic>Population-based studies</topic><topic>Prognosis</topic><topic>Risk</topic><topic>Signs and symptoms</topic><topic>Small intestinal neuroendocrine tumors</topic><topic>Small intestine</topic><topic>Surgery</topic><topic>Survival analysis</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Snorradottir, S.</creatorcontrib><creatorcontrib>Asgeirsdottir, A.</creatorcontrib><creatorcontrib>Rögnvaldsson, S.</creatorcontrib><creatorcontrib>Jonasson, JG</creatorcontrib><creatorcontrib>Björnsson, ES</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Source</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest Healthcare Administration Database</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer epidemiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Snorradottir, S.</au><au>Asgeirsdottir, A.</au><au>Rögnvaldsson, S.</au><au>Jonasson, JG</au><au>Björnsson, ES</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Incidence and prognosis of patients with small intestinal neuroendocrine tumors in a population based nationwide study</atitle><jtitle>Cancer epidemiology</jtitle><date>2022-08</date><risdate>2022</risdate><volume>79</volume><spage>102197</spage><epage>102197</epage><pages>102197-102197</pages><artnum>102197</artnum><issn>1877-7821</issn><eissn>1877-783X</eissn><abstract>Small intestinal neuroendocrine tumours (SI-NETs) are the most frequent malignant tumours of the small intestine. Population based studies on SI-NETs are scarce. We aimed to examine the incidence, presentation of disease and prognosis of SI-NET and to determine patient prognosis in those undergoing emergency or elective surgery.
This was a retrospective population-based study. Information on all patients diagnosed with neuroendocrine tumours of the small intestine (excluding duodenum) from the beginning of the Icelandic Cancer Registry and the pathology departments in the country (1966–2017). Detailed phenotypic information was obtained from medical records on symptoms at diagnosis, treatment, recurrence and survival.
A total of 113 patients with SI-NETs were identified, 3 patients were excluded due to lack of data and/or diagnostic error, leaving 110 patients for final analysis. The incidence of SI-NET was 0.78/100,000 and did not increase during the study period. A total of 42 % (n = 46) of patients were diagnosed incidentally. Long-term prognosis, after a landmark of 12 months, was better in patients who were diagnosed incidentally (HR 0.52; p = 0.03). Overall 89 % (n = 98) of cases underwent surgical resection of the primary tumor, 31 % (n = 30) patients acute or semi-acute surgery and 69 % (n = 68) elective surgery. Emergency surgery was associated with a 6-fold risk of death in the first 12 months after surgery (HR: 5.99; p = 0.01) and associated with more severe surgical complications. However, there was no difference in the long-term risk of death after the first 12 months (HR: 1.39; p = 0.27).
The incidence of SI-NETs has not changed significantly in the last decades. Incidentally diagnosed SI-NET was associated with a favorable long-term prognosis. Emergency surgery in patients with SI-NET was associated with a significantly worse short-term risk of mortality compared to those who underwent elective surgery.
•Despite advances in imaging and endoscopy incidence of SI-NETs did not change over time.•Incidental diagnosis of SI-NET was associated with an earlier stage disease and improved long-term prognosis.•Emergency surgery was associated with a 6-fold risk of death in the first 12 months after surgery.</abstract><cop>New York</cop><pub>Elsevier Ltd</pub><doi>10.1016/j.canep.2022.102197</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1877-7821 |
ispartof | Cancer epidemiology, 2022-08, Vol.79, p.102197-102197, Article 102197 |
issn | 1877-7821 1877-783X |
language | eng |
recordid | cdi_proquest_miscellaneous_2678427464 |
source | ScienceDirect Journals |
subjects | Age groups Cancer Carcinoid Colorectal cancer Complications Data analysis Duodenum Emergencies Epidemiology Error analysis Intestine Lymphatic system Medical prognosis Medical records Medical treatment Metastasis Mortality Neuroendocrine tumors Pathology Patients Population Population studies Population-based studies Prognosis Risk Signs and symptoms Small intestinal neuroendocrine tumors Small intestine Surgery Survival analysis Tumors |
title | Incidence and prognosis of patients with small intestinal neuroendocrine tumors in a population based nationwide study |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T09%3A09%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Incidence%20and%20prognosis%20of%20patients%20with%20small%20intestinal%20neuroendocrine%20tumors%20in%20a%20population%20based%20nationwide%20study&rft.jtitle=Cancer%20epidemiology&rft.au=Snorradottir,%20S.&rft.date=2022-08&rft.volume=79&rft.spage=102197&rft.epage=102197&rft.pages=102197-102197&rft.artnum=102197&rft.issn=1877-7821&rft.eissn=1877-783X&rft_id=info:doi/10.1016/j.canep.2022.102197&rft_dat=%3Cproquest_cross%3E2689039008%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c364t-be3a5a913521f7698d7219472f3a5d530e2af93d0a736ac1d8d7f69541d16c13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2689039008&rft_id=info:pmid/&rfr_iscdi=true |